
Company valuation, historical trends, and peer comparisons.
According to Revive Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.70M. This represents a change of -11.31% compared to the average of 9.81M of the last 4 quarters.
The mean historical Enterprise Value of Revive Therapeutics Ltd. over the last ten years is 37.70M. The current 8.70M Enterprise Value has changed -76.93% with respect to the historical average. Over the past ten years (40 quarters), RVVTF's Enterprise Value was at its highest in in the June 2021 quarter at 171.41M. The Enterprise Value was at its lowest in in the June 2024 quarter at 3.39M.
Average
37.70M
Median
11.56M
Minimum
3.01M
Maximum
143.50M
Discovering the peaks and valleys of Revive Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 750.75%
Maximum Annual Enterprise Value = 143.50M
Minimum Annual Increase = -90.66%
Minimum Annual Enterprise Value = 3.01M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 13.01M | 54.18% |
| 2025 | 8.44M | 180.57% |
| 2024 | 3.01M | -77.57% |
| 2023 | 13.40M | -90.66% |
| 2022 | 143.50M | 1.32% |
| 2021 | 141.64M | 370.88% |
| 2020 | 30.08M | 436.94% |
| 2019 | 5.60M | -44.61% |
| 2018 | 10.11M | 22.66% |
| 2017 | 8.25M | 750.75% |
The current Enterprise Value of Revive Therapeutics Ltd. (RVVTF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.15M
5-year avg
36.27M
10-year avg
37.70M
Revive Therapeutics Ltd.’s Enterprise Value is less than BioNxt Solutions Inc. (40.87M), greater than Pharmadrug Inc. (2.35M), less than Cybin Inc. (57.40M), greater than PharmaTher Holdings Ltd. (4.40M), less than Lobe Sciences Ltd. (12.70M), less than BetterLife Pharma Inc. (149.86M), greater than Bright Minds Biosciences Inc. (-16082441.00), greater than Doseology Sciences Inc. (313.62K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 40.87M | $35.38M | |
| 2.35M | $671.07K | |
| 57.40M | $312.25M | |
| 4.40M | $5.01M | |
| 12.70M | $13.87M | |
| 149.86M | $148.32M | |
| -16082441.00 | $291.88M | |
| 313.62K | $680.99K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revive Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revive Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Revive Therapeutics Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Revive Therapeutics Ltd. (RVVTF)?
What is the 3-year average Enterprise Value for Revive Therapeutics Ltd. (RVVTF)?
What is the 5-year average Enterprise Value for Revive Therapeutics Ltd. (RVVTF)?
How does the current Enterprise Value for Revive Therapeutics Ltd. (RVVTF) compare to its historical average?